Skip to main content
Erschienen in: Reactions Weekly 1/2021

01.12.2021 | Case report

Crizotinib

Nausea, vomiting and drug-induced interstitial lung disease: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Tanimura M, et al. Entrectinib for ROS1-rearranged non-small cell lung cancer after crizotinib-induced interstitial lung disease: A case report. Respirology Case Reports 9: e0857, No. 11, Nov 2021. Available from: URL: http://doi.org/10.1002/rcr2.857 Tanimura M, et al. Entrectinib for ROS1-rearranged non-small cell lung cancer after crizotinib-induced interstitial lung disease: A case report. Respirology Case Reports 9: e0857, No. 11, Nov 2021. Available from: URL: http://​doi.​org/​10.​1002/​rcr2.​857
Metadaten
Titel
Crizotinib
Nausea, vomiting and drug-induced interstitial lung disease: case report
Publikationsdatum
01.12.2021
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-06470-2

Weitere Artikel der Ausgabe 1/2021

Reactions Weekly 1/2021 Zur Ausgabe

Case report

Paclitaxel

Case report

Empagliflozin